Evolution of worldwide consumption of trans fatty acids

Trans Fatty Acids in Human Nutrition: Second Edition

Volumn , Issue , 2009, Pages 329-380

  Craig Schmidt, Margaret C ^a   Rong, Yinghui ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANS FATTY ACID;

FATTY ACIDS;

EID: 79960083637     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9780857097873.329     Document Type: Chapter

References (103)

1. Allison D.B., Egan K., Barraj L.M., Caughman C., Infante M., Heimbach J.T. Estimated intakes of trans fatty and other fatty acids in the US population. J. Am. Diet. Assoc 1999, 99:166-174.
2. American Society for Clinical Nutrition/American Institute for Nutrition (ASCN/AIN) Task Force on Trans Fatty Acids. Position paper on trans fatty acids. Am. J. Clin. Nutr 1996, 63:663-670.
3. ANVISA (Agěncia Nacional de Vigilância Sanitária) National Agency for Sanitary Monitoring Brazil. Mercosul Regulamento Téchnico Sobre Rotulagem Nutricional de Alimentos Embalados 2003, RDS No.360, 23 December, (In Portuguese.).
4. Aro A. Epidemiology of trans fatty acids and coronary heart disease in Europe. Nutr. Metab. Cardiovasc. Dis 1998, 8:402-407.
5. Aro A., Kardinaal A.F., Salminen I., Kark J.D., Riemersma R.A., Delgado-Rodriguez M., Gomez-Aracena J., Huttunen J.K., Kohlmeier L., Martin B.C., Martin-Moreno J.M., Mazaev V.P., Ringstad J., Thamm M., Van't Veer P., Kok F.J. Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC study. Lancet 1995, 345:273-278.
6. Bahrami G., Rahimi Z. Fatty acid composition of human milk in Western Iran. Eur. J. Clin. Nutr 2005, 59:494-497.
7. Baylin A., Kabagambe E.K., Siles X., Campos H. Adipose tissue biomarkers of fatty acid intake. Am. J. Clin. Nutr 2002, 76:750-757.
8. Baylin A., Kabagambe E.K., Ascherio A., Spiegelman D., Campos H. High 18:2 trans-fatty acids in adipose tissue are associated with increased risk of nonfatal acute myocardial infarction in Costa Rican adults. J. Nutr 2003, 133:1186-1191.
9. Bertolino C.N., Castro T.G., Sartorelli D.S., Ferreira S.R., Cardoso M.A. Dietary trans fatty acid intake and serum lipid profile in Japanese-Brazilians in Bauru, São Paulo, Brazil. Cadernos de Saúde Pública 2006, 22:357-364. (In Portuguese.).
10. Beynen A.C., Hermus R.J., Hautvast J.G. A mathematical relationship between the fatty acid composition of the diet and that of the adipose tissue in man. Am. J. Clin. Nutr 1980, 33:81-85.
11. Boué C., Combe N., Billeaud C., Mignerot C., Entressangles B., Thery G., Geoffrion H., Brun J.L., Dallay D., Leng J.J. trans fatty acids in adipose tissue of French women in relation to their dietary sources. Lipids 2000, 35:561-566.
12. Brisson J. Lipids in Human Nutrition: An Appraisal of Some Dietary Concepts 1981, 41-71. Jack K. Burgess Inc, Eaglewood, New Jersey, USA.
13. Canadian Department of Health Regulations amending and food and drug regulations (Nutrition labeling, nutrient content claims and health claims). Canada Gazette, Part II 2003, 137(1):154. 1 January 2003.
14. Cantwell M.M., Flynn M.A., Cronin D., O'neill J.P., Gibney M.J. Contribution of foods to trans unsaturated fatty acid intake in a group of Irish adults. J. Hum. Nutr. Diet 2005, 18:377-385.
15. Cantwell M.M., Gibney M.J., Cronin D., Younger K.M., O'neill J.P., Hogan L., Flynn M.A. Development and validation of a food-frequency questionnaire for the determination of detailed fatty acid intakes. Public Health Nutrition 2005, 8:97-107.
16. Chardigny J.M., Wolff R.L., Mager E., Sébédio J.-L., Martine L., Juanéda P. Trans mono- and polyunsaturated fatty acids in human milk. Eur. J. Clin. Nutr 1995, 49:523-531.
17. Chardigny J.M., Malpuech-Brugere C., Dionisi F., Bauman D.E., German B., Mensink R.P., Combe N., Chaumont P., Barbano D.M., Enjalbert F., Bezelgues J.-B., Cristiani I., Moulin J., Boirie Y., Golay P.-A., Giuffrida F., Sebedio J.-L., Destaillats F. Rationale and design of the TRANSFACT project phase I: a study to assess the effect of the two different dietary sources of trans fatty acids on cardiovascular risk factors in humans. Contemporary Clinical Trials 2006, 27:364-373.
18. Chardigny J.M., Destaillats F., Malpuech-Brugere C., Moulin J., Bauman D.E., Lock A.L., Barbano D.M., Mensink R.P., Bezelgues J.-B., Chaumont P., Combe N., Cristiani I., Joffre F., German J.B., Dionisi F., Boirie Y., Sebedio J.-L. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am. J. Clin. Nutr 2008, 87:558-566.
19. Chen Z.Y., Pelletier G., Hollywood R., Ratanayke W.M. Trans fatty acid isomers in Canadian human milk. Lipids 1995, 30:15-21.
20. Chen Z.Y., Ratnayake W.M., Fortier L., Ross R., Cunnane S.C. Similar distribution of trans-fatty acid isomers in partially hydrogenated vegetable oils and adipose tissue of Canadians. Can. J. Physiol. Pharmacol 1995, 73:718-723.
21. Clifton P.M., Keogh J.B., Noakes M. Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J. Nutr 2004, 134:874-879.
22. Colón-Ramos U., Baylin A., Campos H. The relation between trans fatty acid levels and increased risk of myocardial infarction does not hold at lower levels of trans fatty acids in the Costa Rican food supply. J. Nutr 2006, 136:2887-2892.
23. Combe N., Boué C., Entressangles B. Consommation en acides gras trans et risqué cardio-vasculaire: Étude Aquitaine. Ol. Corps Gras, Lipides 2000, 7:17-24. (In French.).
24. Combe N., Judde A., Boué C., Billeaud C., Entressangles B., Dallay D., Leng J.J., Baste J.C. Composition en acides gras trans du tissu adipeux d'une population francaise et origines alimentaires de ces acides gras. trans. Ol. Corps Gras, Lipides 1998, 5:142-148. (In French.).
25. Craig-Schmidt M.C. Trans-Fatty Acids in Human Nutrition. Worldwide consumption of trans fatty acids 1998, 59-113. The Oily Press, Bridgwater, UK. J.L. Sébédio, W.W. Christie (Eds.).
26. Craig-Schmidt M.C. Isomeric fatty acids: evaluating status and implications for maternal and child health. Lipids 2001, 36:997-1006.
27. Craig-Schmidt M.C. World-wide consumption of trans fatty acids. Atherosclerosis Supplements 2006, 7:1-4.
28. Craig-Schmidt M.C. Trans Fats in Foods. Consumption of trans fatty acids in North America. 2007, 127-153. AOCS Press, Urbana. Illinois, USA. G.R. List, D. Kritchevsky, N. Ratnayake (Eds.).
29. Craig-Schmidt M.C., Weete J.D., Faircloth S.A., Wickwire M.A., Livant E.J. The effect of hydrogenated fat in the diet of nursing mothers on lipid composition and prostaglandin content of human milk. Am. J. Clin. Nutr 1984, 39:778-786.
30. Craig-Schmidt M.C., Teodorescu C.A. Fatty Acids in Foods and Their Health Implications. trans-fatty acids in foods. 2008, 377-437. CRC Press, New York, USA. Third. C.K. Chow (Ed.).
31. DHHS/FDA, Department of Health and Human Services, Food and Drug Administration 2003, 254. 21 CFR Part 101 (Docket No. 94P-0036).
32. Dlouhý P., Tvrzická E., Stanková B., Buchtiková M., Pokorný R., Wiererová O., Bílková D., Rambousková J., Andel M. Trans fatty acids in subcutaneous fat of pregnant women and in human milk in the Czech Republic. Ann. NY Acad. Sci 2002, 967:544-547.
33. Eckel R.H., Borra S., Lichtenstein A.H., Yin-Piazza S.Y., Trans Fat Conference Planning Group Understanding the complexity of trans fatty acid reduction in the American diet: American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group. Circulation 2007, 115:2231-2246.
34. Elias S.L., Innis S.M. Bakery foods are the major dietary source of trans-fatty acids among pregnant women with diets providing 30 percent energy from fat. J. Am. Diet. Assoc 2002, 102:46-51.
35. Enig M.G., Atal S., Keeney M., Sampugna J. Isomeric trans fatty acids in the US Diet. J. Am. Coll. Nutr 1990, 9:471-486.
36. Friesen R., Innis S.M. Trans fatty acids in human milk in Canada declined with the introduction of trans fat food labeling. J. Nutr 2006, 136:2559-2561.
37. FSA UK, Food Standards Agency The Food Labeling Regulations 1996: Guidance Notes. 2003 Internet address:. http://www.food.gov.uk/foodindustry/guidancenotes/labelregsguidance/foodlabelregsguid.
38. Garland M., Sacks F.M., Colditz G.A., Rimm E.B., Sampson L.A., Willett W.C., Hunter D.J. The relation between dietary intake and adipose composition of selected fatty acids in US women. Am. J. Clin. Nutr 1998, 67:25-30.
39. Glew R.H., Herbein J.H., Moya M.H., Valdez J.M., Obadofin M., Wark W.A., Vanderjagt D.J. Trans fatty acids and conjugated linoleic acids in the milk of urban women and nomadic Fulani of northern Nigeria. Clin. Chim. Acta 2006, 367:48-54.
40. Harnack L., Lee S., Schakel S.F., Duval S., Luepker R.V., Arnett D.K. Trends in the trans-fatty acid composition of the diet in a metropolitan area: the Minnesota Heart Survey. J. Am. Diet. Assoc 2003, 103:1160-1166.
41. Hayat L., Al-Sughayer M.A., Afzal M. Fatty acid composition of human milk in Kuwaiti mothers. Comp. Biochem. Physiol 1999, 124:261-267. Part B: Biochemistry & Molecular Biology.
42. Hirsch J., Farquhar J.W., Ahrens E.H., Peterson M.L., Stoffel W. Studies of adipose tissue in man: a microtechnic for sampling and analysis. Am. J. Clin. Nutr 1960, 8:499-511.
43. Hu F.B., Stampler M.D., Manson J.E., Rimm E., Colditz G.A., Rosner B.A., Hennekens C.H., Willett W.C. Dietary fat intake and the risk of coronary heart disease in women. New Eng. J. Med 1997, 337:1491-1499.
44. Hu F.B., Stampfer M.J., Manson J.E., Grodstein F., Colditz G.A., Speizer F.E., Willett W.C. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. New Eng. J. Med 2000, 343:530-537.
45. Hulshof K.F., Van Erp-Baart M.A., Anttolainen M., Becker W., Church S.M., Couet C., Herman-Kunz E., Kesteloot H., Leth T., Martins I., Moreiras O., Moschandreas J., Pizzoferrato L., Rimestad A.H., Thorgeirsdottir H., Van Amelsvoort J.M., Aro A., Kafatos A.G., Lanzmann-Petithory D., Van Poppel G. Intake of fatty acids in Western Europe with emphasis on trans fatty acids: the TRANSFAIR Study. Eur. J. Clin. Nutr 1999, 53:143-157.
46. Hunter J.E. Dietary trans fatty acids: review of recent human studies and food industry responses. Lipids 2006, 41:967-992.
47. Innis S.M., Green T.J., Halsey T.K. Variability in the trans fatty acid content of foods within a food category: implications for estimation of dietary trans fatty acid intake. J. Am. Coll. Nutr 1999, 18:255-260.
48. Innis S.M., King D.J. Trans fatty acids in human milk are inversely associated with concentrations of essential all-cis n-6 andn-3 fatty acids and determine trans, but notn-6 andn-3, fatty acids in plasma lipids of breast-fed infants. Am. J. Clin. Nutr 1999, 70:383-390.
49. Innis S.M., Vaghri Z., King D.J. n-6 Docosapentaenoic acid is not a predictor of low docosahexaenoic acid status in Canadian preschool children. Am. J. Clin. Nutr 2004, 80:768-773.
50. International Life Sciences Institute (ILSI) Expert Panel on Trans Fatty Acids and Coronary Heart Disease. Trans fatty acids and coronary heart disease risk. Am. J. Clin. Nutr. 1995, 62:655S-708S.
51. International Life Sciences Institute (ILSI) Expert Panel on Trans Fatty Acids and Early Development. Trans fatty acids: infant and fetal development. Am. J. Clin. Nutr. 1997, 66:715S-736S.
52. Jakobsen M.U., Bysted A., Andersen N.L., Heitmann B.L., Hartkopp H.B., Leth T., Overvad K., Dyerberg J. Intake of ruminant trans fatty acids in the Danish population aged 1-80 years. Eur. J. Clin. Nutr 2006, 60:312-318.
53. Jakobsen M.U., Overvad K., Dyerberg J., Heitmann B.L. Intake of ruminant trans fatty acids and risk of coronary heart disease. Int. J. Epidemiology 2008, 37:173-182.
54. Jensen R.G. Lipids in human milk. Lipids 1999, 34:1243-1271.
55. Johansson L., Borgejordet A., Pedersen J.I. Trans fatty acids in the Norwegian diet. Tidsskrift for den Norske Legeforening 2006, 126:760-763. (In Norwegian.).
56. Katan M.B. Regulation of trans fats: the gap, the Polder, and McDonald's French fries. Atherosclerosis Supplements 2006, 7:63-66.
57. King I.B., Kristal A.R., Schaffer S., Thornquist M., Goodman G.E. Serum trans-fatty acids are associated with risk of prostate cancer in beta-carotene and retinol efficacy trial. Cancer Epidemiology, Biomarkers & Prevention 2005, 14:988-992.
58. Kromhout D., Menotti A., Bloemberg B., Aravanis C., Blackburn H., Buzina R., Dontas A.S., Fidanza F., Giampaoli S., Jansen A., Karvonen M., Katan M., Nissinen A., Nedeljkovic S., Pekkanen J., Pekkarinen M., Punsar S., Rasanen L., Simic B., Toshima H. Dietary saturated and trans-fatty acids and cholesterol and 25-year mortality from coronary heart disease: The Seven Countries Study. Preventive Medicine 1995, 24:308-315.
59. Lee S., Harnack L., Jacobs D.R., Steffen L.M., Luepker R.V., Arnett D.K. Trends in diet quality for coronary heart disease prevention between 1980-1982 and 2000-2002: The Minnesota Heart Survey. J. Am. Diet. Assoc 2007, 107:213-222.
60. Lemaitre R.N., King I.B., Mozaffarian D., Sotoodehnia N., Rea T.D., Kuller L.H., Tracy R.P., Siscovick D.S. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation 2006, 114:209-215.
61. Lemaitre R.N., King I.B., Patterson R.E., Psaty B.M., Kestin M., Heckbert S.R. Assessment of trans-fatty acid intake with a food frequency questionnaire and validation with adipose tissue levels of trans-fatty acids. Am. J. Epidemiology 1998, 148:1085-1093.
62. Lemaitre R.N., King I.B., Raghunathan T.E., Pearce R.M., Weinmann S., Knopp R.H., Copass M.K., Cobb L.A., Siscovick D.S. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 2002, 105:697-701.
63. Leth T., Bysted A., Hansen K., Ovesen L. trans-fatty acid content in Danish margarines and shortenings. J. Am. Oil Chem. Soc 2003, 80:475-478.
64. Leth T., Jensen H.G., Mikkeksen A.A., Bysted A. The effect of the regulation on trans fatty acid content in Danish food. Atherosclerosis Supplements 2006, 7:53-56.
65. Liu X., Schumacher F.R., Plummer S.J., Jorgenson E., Casey G., Witte J.S. trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant. Carcinogenesis 2007, 28:1232-1236.
66. Lopes C., Aro A., Azevedo A., Ramos E., Barros H. Intake and adipose tissue composition of fatty acids and risk of myocardial infarction in a male Portuguese community sample. J. Am. Diet. Assoc 2007, 107:276-286.
67. Lopez-Garcia E., Schulze M.B., Manson J.E., Meigs J.B., Albert C.M., Rifai N., Willett W.C., Hu F.B. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J. Nutr 2004, 134:1806-1811.
68. Lopez-Garcia E., Schulze M.B., Meigs J.B., Manson J.E., Rifai N., Stampfer M.J., Willett W.C., Hu F.B. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr 2005, 135:562-566.
69. Lu M., Taylor A., Chylack L.T., Rogers G., Hankinson S.E., Willett W.C., Jacques P.F. Dietary fat intake and early age-related lens opacities. Am. J. Clin. Nutr 2005, 81:773-779.
70. Mann N.J., Sinclair A.J., Percival P., Lewis J.L., Meyer B.J., Howe P.R.C. Development of a database of fatty acids in Australian foods. Nutr. Diet 2003, 60:42-45.
71. Mcnaughton S.A., Hughes M.C., Marks G.C. Validation of a FFQ to estimate the intake of PUFA using plasma phospholipid fatty acids and weighed foods records. Brit. J. Nutr 2007, 97:561-568.
72. Mensink R.P., Katan M.B. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. New Eng. J. Med 1990, 323:439-445.
73. Mojska H., Socha P., Socha J., Soplinska E., Jaroszewska-Balicka W., Szponar L. trans fatty acids in human milk in Poland and their association with breastfeeding mothers' diets. Acta Paediatrica 2003, 92:1381-1387.
74. Monge-Rojas R., Campos H., Fernández Rojas X. Saturated andcis- and trans-unsaturated fatty acids intake in rural and urban Costa Rican adolescents. J. Am. Coll. Nutr 2005, 24:286-293.
75. Mosley E.E., Wright A.L., Mcguire M.K., Mcguire M.A. trans fatty acids in milk produced by women in the United States. Am. J. Clin. Nutr 2005, 82:1292-1297.
76. Motard-Belanger A., Charest A., Grenier G., Paquin P., Chouinard Y., Lemieux S., Couture P., Lamarche B. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am. J. Clin. Nutr 2008, 87:593-599.
77. Mozaffarian D., Abdollahi M., Campos H., Houshiarrad A., Willett W.C. Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur. J. Clin. Nutr 2007, 61:1004-1010.
78. Mozaffarian D., Katan M.B., Ascherio A., Stampfer M.J., Willett W.C. trans fatty acids and cardiovascular disease. New Eng. J. Med 2006, 354:1601-1613.
79. Mozaffarian D., Pischon T., Hankinson S.E., Rifai N., Joshipura K., Willett W.C., Rimm E.B. Dietary intake of trans fatty acids and systemic inflammation in women. Am. J. Clin. Nutr 2004, 79:606-612.
80. Mozaffarian D., Rimm E.B., King I.B., Lawler R.L., Mcdonald G.B., Levy W.C. trans fatty acids and systemic inflammation in heart failure. Am. J. Clin. Nutr 2004, 80:1521-1525.
81. Oomen C.M., Ocké M.C., Feskens E.J., Van Erp-Baart M.A., Kok F.J., Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 2001, 357:746-751.
82. Pedersen J.I., Johansson L., Thelle D.S. Trans fatty acids and health. Tidsskr Nor Laegeforen 1998, 118:3474-3480. (in Norwegian.).
83. Precht D., Molkentin J. C18:1, C18:2 and C18:3 trans and cis fatty acid isomers including conjugated cis delta 9, trans delta 11 linoleic acid (CLA) as well as total fat composition of German human milk lipids. Die Nahrung 1999, 43:233-244.
84. Ratnayake W.M.N., Chen Z.Y. trans fatty acids in Canadian breast milk and diet. Development and Processing of Vegetable Oils for Human Nutrition 1995, 20-35. AOCS Press, Champaign, Illinois, USA. R. Przybylski, B.E. Mcdonald (Eds.).
85. Roberts T.L., Wood D.A., Riemersma R.A., Gallagher P.J., Lampe F.C. Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet 1995, 345:278-282.
86. Schrimpf-Moss J., Wilkening V. Trans Fats in Foods. Labeling of trans fatty acids. 2007, 177-191. AOCS Press, Urbana, Illinois. G.R. List, D. Kritchevsky, N. Ratnayake (Eds.).
87. Health Aspects of Dietary Trans Fatty Acids 1985, F.R. Senti (Ed.).
88. Skeaff C.M., Gowans S. Home use of margarine is an important determinant of plasma trans fatty acid status: a biomarker study. Brit. J. Nutr 2006, 96:377-383.
89. Stender S., Dyerberg J. The Influence of Trans Fatty Acids on Health. A Report From the Danish Nutrition Council 2003, Publication no.34. Fourth.
90. Stender S., Dyerberg J., Astrup A. High levels of industrially produced trans fat in popular fast foods. New Eng. J. Med 2006, 354:1650-1652.
91. Sun Q., Ma J., Campos H., Hankinson S.E., Hu F.B. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am. J. Clin. Nutr 2007, 86:74-81.
92. Sun Q., Ma J., Campos H., Hankinson S.E., Manson J.E., Stampfer M.J., Rexrode K.M., Willett W.C., Hu F.B. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 2007, 115:1858-1865.
93. Tarrago-Trani M.T., Phillips K.M., Lemar L.E., Holden J.M. New and existing oils and fats used in products with reduced trans-fatty acid content. J. Am. Diet. Assoc 2006, 106:867-880.
94. Tsai C.J., Leitzmann M.F., Willett W.C., Giovannucci E.L. Long-term intake of trans-fatty acids and risk of gallstone disease in men. Arch. Int. Med 2005, 165:1011-1015.
95. Van De Vijver L.P.L., Van Poppel G., Van Houwelingen A., Kruyssen D.A., Hornstra G. Trans unsaturated fatty acids in plasma phospholipids and coronary heart disease: a case-control study. Atherosclerosis 1996, 126:155-161.
96. Van De Vijver L.P., Kardinaal A.F., Couet C., Aro A., Kafatos A., Steingrimsdottir L., Amorim Cruz J.A., Moreiras O., Becker W., Van Amelsvoort J.M., Vidal-Jessel S., Salminen I., Moschandreas J., Sigfússon N., Martins I., Carbajal A., Ytterfors A., Poppel G. Association between trans fatty acid intake and cardiovascular risk factors in Europe: the TRANSFAIR study. Eur. J. Clin. Nutr 2000, 54:126-135.
97. Voorrips L.E., Brants H.A., Kardinaal A.F., Hiddin G.J., Van Den Brandt P.A., Goldbohm R.A. Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer. Am. J. Clin. Nutr 2002, 76:873-882.
98. Weggemans R.M., Rudrum M., Trautwein E.A. Intake of ruminant versus industrial trans fatty acids and risk of coronary heart disease - what is the evidence?. Eur. J. Lipid. Sci. Technol 2004, 106:390-397.
99. Willett W., Mozaffarian D. Ruminant or industrial sources of trans fatty acids: public health issue or food label skirmish?. Am. J. Clin. Nutr 2008, 87:515-516.
100. Wolff R.L. Content and distribution of trans-18:1 acids in ruminant milk and meat fats. Their importance in European diets and their effect on human milk. J. Am. Oil Chem. Soc 1995, 72:259-272.
101. Wolff R.L., Precht D., Molkentin J. Trans-18:1 acid content and profile in human milk lipids. Critical survey of data in connection with analytical methods. J. Am. Oil Chem. Soc 1998, 75:661-671.
102. Zhou B.F., Stamler J., Dennis B., Moag-Stahlberg A., Okuda N., Robertson C., Zhao L., Chan Q., Elliott P., INTERMAP Research Group Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J. Hum. Hypertens 2003, 17:623-630.
103. Zock P.L., Katan M.B. Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J. Lipid Res 1992, 33:399-410.